Aptose Biosciences Inc. (APTOF)
OTCMKTS · Delayed Price · Currency is USD
1.190
+0.110 (10.19%)
Oct 6, 2025, 4:00 PM EDT

Aptose Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3142053122390
Upgrade
Market Cap Growth
-54.19%-32.53%-62.12%-56.27%-68.80%-9.61%
Upgrade
Enterprise Value
14163-327252
Upgrade
Last Close Price
1.196.7676.20261.00607.501971.00
Upgrade
PB Ratio
-0.21-2.99-6.941.411.643.28
Upgrade
P/TBV Ratio
---1.411.643.28
Upgrade
Debt / Equity Ratio
-0.79-2.34-0.350.040.010.01
Upgrade
Quick Ratio
0.061.380.613.829.6817.97
Upgrade
Current Ratio
0.362.140.784.0310.0018.36
Upgrade
Return on Equity (ROE)
---293.95%-74.70%-67.67%-51.91%
Upgrade
Return on Assets (ROA)
-162.74%-141.99%-102.23%-39.87%-39.18%-30.75%
Upgrade
Return on Capital (ROIC)
--779.60%-176.13%-46.77%-42.00%-32.36%
Upgrade
Earnings Yield
-699.52%-187.07%-254.17%-78.63%-53.73%-14.17%
Upgrade
FCF Yield
-900.03%-264.70%-221.47%-60.81%-35.77%-8.71%
Upgrade
Buyback Yield / Dilution
-337.23%-210.44%-9.81%-3.57%-8.86%-63.15%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.